Tata India Pharma & Healthcare Fund vs Mirae Asset Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Mirae Asset Healthcare Fund -Regular Growth
Chart Comparison
Overview
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1208 Cr | ₹2652 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 28 Dec 2015 | 02 Jul 2018 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | Nifty Pharma TRI | BSE Healthcare |
Turn Over | 26.49% | 15% |
Expense Ratio | 2.14 | 1.92 |
Manager | Meeta Shetty | Vrijesh Kasera |
ISIN Code | INF277K016A9 | INF769K01EA2 |
Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | Mirae Asset Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
1 Month | 7.78% | 9.05% |
6 Month | -8.77% | -7.09% |
1 Year | 14.26% | 17.24% |
3 Year | 18.94% | 17.98% |
5 Year | 27.67% | 28.96% |
SIP Return Analysis
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
6 Month | -5.45% | -3.4% |
1 Year | -0.3% | 3.98% |
3 Year | 23.71% | 23.76% |
5 Year | 19.72% | 19.66% |
Rolling Lumpsum Returns
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
1 Year | 7.82% | 24.74% |
3 Year | 17.79% | 19.07% |
5 Year | 14.55% | 24.52% |
Risk Management
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Standard Deviation | 16.538% | 16.629% |
Sharp | 0.681% | 0.604% |
Beta | 0.969% | 0.974% |
Alpha | 0.018% | -1.264% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Name | Meeta Shetty | Vrijesh Kasera |
Total AUM | ₹17847 Cr | ₹12061 Cr |
Funds Managed | 5 | 4 |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
Market Cap
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Others | 5.06 | 2.93 |
Small Cap | 27.82 | 23.32 |
Large Cap | 35.26 | 34.72 |
Mid Cap | 31.87 | 39.03 |
Sector Allocation
Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Others | 4.34 | 0.17 |
Basic Materials | 2.22 | 0.74 |
Healthcare | 93.44 | 98.36 |
Industrials | - | 0.73 |
Top Comparisons
UTI QUARTERLY INTERVAL FUND II REGULAR PLAN GROWTH
3Y Returns6.03%
UTI QUARTERLY INTERVAL FUND II REGULAR PLAN GROWTH
3Y Returns6.03%
HDFC Hybrid Debt Fund - Growth Plan
3Y Returns10.27%
DSP Regular Savings Fund- Regular Plan - Growth
3Y Returns9.27%
Nippon India Innovation Fund - Regular (G)
3Y Returns0%
UTI-Transpotation and Logistics Fund-Growth Option
3Y Returns22.63%
Nippon India Balanced Advantage Fund-Growth Plan-Bonus Option
3Y Returns11.83%
Baroda BNP Paribas Balanced Advantage Fund-Regular Plan -Growth Option
3Y Returns12.21%